| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TXG | Class A Common Stock | Options Exercise | $209,997 | +41,666 | +88% | $5.04* | 88,783 | 01 Sep 2021 | Direct | F1 |
| transaction | TXG | Class A Common Stock | Sale | $182,935 | -1,049 | -1.2% | $174.39 | 87,734 | 01 Sep 2021 | Direct | F1, F2 |
| transaction | TXG | Class A Common Stock | Sale | $479,292 | -2,728 | -3.1% | $175.69 | 85,006 | 01 Sep 2021 | Direct | F1, F3 |
| transaction | TXG | Class A Common Stock | Sale | $1,330,156 | -7,530 | -8.9% | $176.65 | 77,476 | 01 Sep 2021 | Direct | F1, F4 |
| transaction | TXG | Class A Common Stock | Sale | $3,757,830 | -21,145 | -27% | $177.72 | 56,331 | 01 Sep 2021 | Direct | F1, F5 |
| transaction | TXG | Class A Common Stock | Sale | $1,533,138 | -8,586 | -15% | $178.56 | 47,745 | 01 Sep 2021 | Direct | F1, F6 |
| transaction | TXG | Class A Common Stock | Sale | $112,536 | -628 | -1.3% | $179.20 | 47,117 | 01 Sep 2021 | Direct | F1, F7 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TXG | Stock Option (right to buy) | Options Exercise | $0 | -41,666 | -29% | $0.000000 | 102,782 | 01 Sep 2021 | Class A Common Stock | 41,666 | $5.04 | Direct | F1, F8 |
| Id | Content |
|---|---|
| F1 | The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. |
| F2 | This transaction was executed in multiple trades at prices ranging from $174.14 to $175.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F3 | This transaction was executed in multiple trades at prices ranging from $175.14 to $176.135. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F4 | This transaction was executed in multiple trades at prices ranging from $176.14 to $177.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F5 | This transaction was executed in multiple trades at prices ranging from $177.14 to $178.13. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F6 | This transaction was executed in multiple trades at prices ranging from $178.14 to $179.13. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F7 | This transaction was executed in multiple trades at prices ranging from $179.14 to $179.31. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F8 | This option, originally for 175,000 shares, of which 72,218 shares have been exercised, vested as to one forty-eighth of the shares on October 1, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |
Chief Scientific Officer and President